Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Gilley

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Nature Communications|September 17, 2024
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD productionJames R Tribble, Melissa Jöe, Carmine Varricchio, et al.
Nature Communications|July 24, 2024
NMNAT2 is a druggable target to drive neuronal NAD productionJames R Tribble, Melissa Jöe, Carmine Varricchio, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Science (New York, N.Y.)|August 24, 2019
NAD<sup>+</sup> cleavage activity by animal and plant TIR domains in cell death pathwaysShane Horsefield, Hayden Burdett, Xiaoxiao Zhang, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Nature Communications|September 17, 2024
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD productionJames R Tribble, Melissa Jöe, Carmine Varricchio, et al.
Nature Communications|July 24, 2024
NMNAT2 is a druggable target to drive neuronal NAD productionJames R Tribble, Melissa Jöe, Carmine Varricchio, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Science (New York, N.Y.)|August 24, 2019
NAD<sup>+</sup> cleavage activity by animal and plant TIR domains in cell death pathwaysShane Horsefield, Hayden Burdett, Xiaoxiao Zhang, et al.
Pageof 5